Cyteir Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q1 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Cyteir Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2022 to Q3 2023.
Cyteir Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2023 was $16K, a 99.4% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$16K	-$2.63M	-99.4%	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$57K	-$2.78M	-98%	Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$98K	-$2.93M	-96.8%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$2.45M			Dec 31, 2022	10-Q	2023-11-06
Q3 2022	$2.65M			Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$2.84M			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$3.03M			Mar 31, 2022	10-Q	2022-05-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.